BIBLIOGRAFÍA FUNDAMENTAL:
Genética en medicina.Margaret W. Thompson,Robert L. Nussbaum,James Scott Thompson,Roderick R. McInnes,Huntington F. Williard. Elsevier España, 2004.
Genética humana: fundamentos y aplicaciones en medicina.Alberto Juan Solari. Médica Panamericana, 1999.
Genética médica.Lynn B. Jorde. Elsevier España, 2004.
Genética médica.Rafael Oliva Virgili. Edicions Universitat Barcelona, 2004.
Hardman, J. G., L. E. Limbird, and A. Goodman Gilman. Goodman & Gilman's The Pharmacological Basis of Therapeutics (10th Ed.). Mc Graw Hill, 2001.
Licinio, J. and M.-L. Wong. Pharmacogenomics : The Search for Individualized Therapies. John Wiley & Sons, 2002.
Rothstein, M. A. Pharmacogenomics: Social, Ethical, and Clinical Dimensions.Wiley-Liss, 2003.
1. Lander ES, et al. Initial sequencing and analysis of the human genome. Nature, 2001; 409: 860-921.
2. Venter JC, et al. The sequence of the human genome. Science, 2001; 291: 1304-1351.
3. Jimenez-Sanchez G, et al. Human disease genes. Nature, 2001; 409: 853-855.
4. Sachidanandam R, et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature, 2001; 409: 928-933.
5. Jimenez-Sanchez G. La Medicina Genómica: Un nuevo paradigma en el cuidado de la salud. Medica Sur, 2000; 7: 4-5.
6. Lim et al. Psychosocial Group Short- and long-term impact of receiving genetic mutation results in women at increased risk for hereditary breast cancer. J. Genet Couns 2004;13 (2): 115-33.7. Taylor GR and JNM Day (Editors). Guide to mutation detection, John Wiley and sons, 2005.8. Rapley R, Theophilus DMB. PCR mutation detection protocols: Methods in Molecular Biology, Rapley R Editor. 2002.9. Sambrook J, Russell DW, Molecular Cloning: A laboratory manual, 3ª Edition. New York: Cold Spring Harbour Laboratory Press, 2001.10. Esteban-Cardenosa E et al. High-throughput mutation detection method to scan BRCA1 and BRCA2 based on heteroduplex analysis by capillary array electrophoresis. Clin Chem 2004; 50: 313-20.11. CastellSagué E et al. Detection of APC gene deletions using quantitative multiplex PCR of short fluorescent fragments. Clin Chem. 2008 Jul;54(7):1132-40.Altman, R. B, and T. E. Klein. (2002). Challenges for biomedical informatics and pharmacogenomics. Ann. Rev. Pharmacol. Toxicol. 42:113-133 176
12.Arranz, M. J., J. Munro, S. Osborne, D. Collier, and R. W. Kerwin (2001). Applications of pharmacogenetics in psychiatry: personalisation of treatment. Exp. Op. Pharmacother. 2(4), 537-542.
13.Chicurel ME, Dalma-Weiszhausz DD. (2002). Microarrays in pharmacogenomics-advances and future promise. Pharmacogenomics 3(5):589-601.
14. Daly, A. K., and A. G. Hall. (2001). Pharmacogenetics of cytotoxic drugs. Exp. Rev. Anticancer Ther. 1(2), 301-308.
15. Evans, W. E., and M. V. Relling. (1999). Pharmacogenomics: translating functional genomics into rational therapeutics. Science 286: 487–491.
16. Furness, L. M., S. Henrichwark, and M. Egerton (2000). Expression databases - resources for pharmacogenomic R&D. Pharmacogenomics 1: 281-288.
17.Lindpaintner, K. (2002). The impact of pharmacogenetics and pharmacogenomics on drug discovery. Nat Rev Drug Discov. 1(6):463-469.
18.March, R., K. Cheeseman, and M. Doherty(2001). Pharmacogenetics - legal, ethical and regulatory considerations. Pharmacogenomics 2: 317-327.
